JNJ acquires ITCI for $132.00/sh cash—a 60% premium to the “unaffected” closing price on 1/9/25: https://finance.yahoo.com/news/johnson-johnson-strengthens-neuroscience-leadership-113200603.html The nominal deal value is $14.6B.